Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 17126 - 17150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ciprofloxacin	Approved Investigational	MMP13	4322	downregulated	Ciprofloxacin results in decreased expression of MMP13 mRNA	11q22.2	A21669
Ciprofloxacin	Approved Investigational	MMP3	4314	upregulated	Ciprofloxacin results in increased expression of MMP3 mRNA	11q22.2	A21668
Ciprofloxacin	Approved Investigational	SLC2A1	6513	downregulated	Ciprofloxacin results in decreased expression of SLC2A1 mRNA	1p34.2	A21670
Ciprofloxacin	Approved Investigational	TGFB1	7040	upregulated	Ciprofloxacin results in increased expression of TGFB1 mRNA	19q13.1	A21671
Citalopram	Approved Investigational	AHR	196	downregulated	Citalopram results in decreased expression of AHR mRNA	7p21.1	A21672
Citalopram	Approved Investigational	FABP1	2168	upregulated	Citalopram results in increased expression of FABP1 mRNA	2p11.2	A20646
Citalopram	Approved Investigational	GDPD3	79153	upregulated	Citalopram results in increased expression of GDPD3 mRNA	16p11.2	A20646
Citalopram	Approved Investigational	HMGCS1	3157	upregulated	Citalopram results in increased expression of HMGCS1 mRNA	5p12	A20655
Citalopram	Approved Investigational	INHBE	83729	upregulated	Citalopram results in increased expression of INHBE mRNA	12q13.3	A20646
Citalopram	Approved Investigational	NUPR1	26471	upregulated	Citalopram results in increased expression of NUPR1 mRNA	16p11.2	A20646
Citalopram	Approved Investigational	SCD	6319	upregulated	Citalopram results in increased expression of SCD mRNA	10q24.31	A20655
Citalopram	Approved Investigational	SERPINA3	12	upregulated	Citalopram results in increased expression of SERPINA3 mRNA	14q32.13	A20646
Citalopram	Approved Investigational	SLC2A3	6515	downregulated	Citalopram results in decreased expression of SLC2A3 mRNA	12p13.31	A20646
Citalopram	Approved Investigational	TAGLN	6876	downregulated	Citalopram results in decreased expression of TAGLN mRNA	11q23.2	A20646
Citric acid	Approved Investigational Nutraceutical Vet Approved	ANGPTL3	27329	upregulated	Citric Acid results in increased expression of ANGPTL3 mRNA	1p31.3	A20645
Clarithromycin	Approved Investigational	ASAH1	427	upregulated	Clarithromycin results in increased expression of ASAH1 mRNA	8p22	A20438
Clarithromycin	Approved Investigational	CYP3A4	1576	downregulated	Clarithromycin results in decreased expression of CYP3A4 mRNA	7q22.1	A20983
Clarithromycin	Approved Investigational	INHBE	83729	upregulated	Clarithromycin results in increased expression of INHBE mRNA	12q13.3	A20438
Clarithromycin	Approved Investigational	LSS	4047	downregulated	Clarithromycin results in decreased expression of LSS mRNA	21q22.3	A20438
Clarithromycin	Approved Investigational	PHYH	5264	downregulated	Clarithromycin results in decreased expression of PHYH mRNA	10p13	A20438
Clindamycin	Approved Investigational Vet Approved	CYP3A4	1576	upregulated	Clindamycin results in increased expression of CYP3A4 mRNA	7q22.1	A15703
Clindamycin	Approved Investigational Vet Approved	MMP13	4322	upregulated	Clindamycin results in increased expression of MMP13 mRNA	11q22.2	A21620
Clioquinol	Approved Vet Approved Withdrawn	AK1	203	downregulated	Clioquinol results in decreased expression of AK1 mRNA	9q34.11	A21673
Clioquinol	Approved Vet Approved Withdrawn	BNIP3L	665	downregulated	Clioquinol results in decreased expression of BNIP3L mRNA	8p21.2	A21673
Clioquinol	Approved Vet Approved Withdrawn	CDKN1A	1026	upregulated	Clioquinol results in increased expression of CDKN1A mRNA	6p21.2	A21674

Displaying entries 17126 - 17150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability